Trastuzumab in the treatment of advanced non-small-cell lung cancer: Is there a role? - Reply

被引：0
作者：
Langer, CJ [1 ]
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 06期
关键词：
D O I：
10.1200/JCO.2005.05.297
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1326 / 1327
页数：2
相关论文
共 4 条
[1]   Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer [J].
Gatzemeier, U ;
Groth, G ;
Butts, C ;
Van Zandwijk, N ;
Shepherd, F ;
Ardizzoni, A ;
Barton, C ;
Ghahramani, P ;
Hirsh, V .
ANNALS OF ONCOLOGY, 2004, 15 (01) :19-27
[2]   Trastuzumab in the treatment of advanced non-small-cell lung cancer: Is there a role? Focus on eastern cooperative oncology group study 2598 [J].
Langer, CJ ;
Stephenson, P ;
Thor, A ;
Vangel, M ;
Johnson, DH .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1180-1187
[3]   Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J].
Schiller, JH ;
Harrington, D ;
Belani, CP ;
Langer, C ;
Sandler, A ;
Krook, J ;
Zhu, JM ;
Johnson, DH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02) :92-98
[4]  
VERMA S, 2001, P AN M AM SOC CLIN, V20, pA347
1